← FDA Drug Approvals (Drugs@FDA)

ACETAMINOPHEN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BAXTER HLTHCARE CORP · Approved 2021-09-17

Drug application

FDA Application #

ANDA214331

Application type

Abbreviated New Drug Application (Generic)

Brand name

ACETAMINOPHEN

Generic name

ACETAMINOPHEN

Active ingredients

ACETAMINOPHEN

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

BAXTER HLTHCARE CORP

Manufacturer

Baxter Healthcare Corporation

First approval

2021-09-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown